Consequently, CELF2 promotes the conversion of CD44s to CD44v isoform, which acts as a regulator that protects against the progression of pancreatic cancer through the endoplasmic reticulum‐associated degradation signalling pathway.119. This evidence concerns the gene CELF2 and familial pancreatic carcinoma.